Migraine Studies
A clinical research study called the C-BEOND Study is looking at whether abobotulinum
toxin A injections can help reduce or prevent the number of migraine attacks in adults
with chronic migraine.
The C-BEOND Study is recruiting individuals who:
– Are aged at least 18 years
– Have been diagnosed with chronic migraine at least 12 months ago
– Started to have migraines before the age of 50 years
– Typically spend at least 15 days a month with a headache out of which at least 8
of these headache days are days with a migraine
Abobotulinum toxin A (Dysport®) is approved for a number of medical and cosmetic
uses but not currently for migraine.
For more information about the C-BEOND study, and to see if you may qualify,
please email ResearchNCNE@neurocenterne.com / call 781-551-5812 opt.2.
A clinical research study called the E-BEOND Study is looking at whether abobotulinum
toxin A injections can help reduce or prevent the number of migraine attacks in adults
with episodic migraine.
The E-BEOND Study is recruiting individuals who:
– Are aged at least 18 years
– Have been diagnosed with migraine at least 12 months ago
– Started to have migraines before the age of 50 years
– Typically spend less than 15 days a month with a headache out of which at least
6 of these headache days are days with a migraine
– Have previously used, or are currently using, preventative treatment for migraine
Abobotulinum toxin A (Dysport®) is approved for a number of medical and cosmetic
uses but not currently for migraine.
For more information about the E-BEOND study, and to see if you may qualify,
please email ResearchNCNE@neurocenterne.com / call 781-551-5812 opt.2.
